StockData
Scinai Immunotherapeutics Ltd. logo

Scinai Immunotherapeutics Ltd. (SCNI) stock

SCNINasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 1, 2026Score 6/30
$0.37−0.01 (-1.40%)

Close on Nov 18, 2026Market cap $1.27MP/E –Yield –

Scinai Immunotherapeutics revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

For fiscal 2025 it was $1.31M, up 99.2% from the year before.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$1.31M+99.2%
FY2024Dec 31, 2024$658.00K–

More Scinai Immunotherapeutics figures

See a number that looks wrong?